These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 15202848)
61. The efficacy of oral tegafur-uracil as maintenance therapy following intravenous 5-fluorouracil chemotherapy in stage III colon cancer. Hong KD; Lee SI; Moon HY Hepatogastroenterology; 2012; 59(113):104-7. PubMed ID: 22251527 [TBL] [Abstract][Full Text] [Related]
62. Risk factors for 6-month continuation of S-1 adjuvant chemotherapy for resected pancreatic cancer. Aoyama T; Katayama Y; Murakawa M; Asari M; Kanazawa A; Higuchi A; Shiozawa M; Kobayashi S; Ueno M; Morimoto M; Ohkawa S; Akaike M; Yamamoto N; Yoshikawa T; Rino Y; Masuda M; Morinaga S Cancer Chemother Pharmacol; 2014 Dec; 74(6):1235-40. PubMed ID: 25297990 [TBL] [Abstract][Full Text] [Related]
65. [Effect of Post-Gastrectomy Adjuvant S-1 Chemotherapy on Muscle Volume in Gastric Cancer Patients]. Iwazawa T; Kawanishi K; Fujita J; Takata A; Hirota M; Imamura H; Ikeda A; Hokonohara K; Yoneyama C; Kameyama A; Shinke G; Oshima K; Tanida T; Hatano H; Noda T; Komori T; Morita S; Akagi K; Dono K Gan To Kagaku Ryoho; 2015 Aug; 42(8):957-60. PubMed ID: 26321709 [TBL] [Abstract][Full Text] [Related]
66. Body weight loss after surgery is an independent risk factor for continuation of S-1 adjuvant chemotherapy for gastric cancer. Aoyama T; Yoshikawa T; Shirai J; Hayashi T; Yamada T; Tsuchida K; Hasegawa S; Cho H; Yukawa N; Oshima T; Rino Y; Masuda M; Tsuburaya A Ann Surg Oncol; 2013 Jun; 20(6):2000-6. PubMed ID: 23242818 [TBL] [Abstract][Full Text] [Related]
67. Blue Lunula Due to a Combination Chemotherapy Not Reported Before. Pangti R; Gupta S Indian Dermatol Online J; 2022; 13(4):546-547. PubMed ID: 36262576 [No Abstract] [Full Text] [Related]
68. Nail Changes With Chemotherapeutic Agents and Targeted Therapies. Mittal S; Khunger N; Kataria SP Indian Dermatol Online J; 2022; 13(1):13-22. PubMed ID: 35198463 [TBL] [Abstract][Full Text] [Related]
69. [The current status of adjuvant chemotherapy of colonic cancer]. Takiuchi H Gan To Kagaku Ryoho; 2009 Nov; 36(11):1826-8. PubMed ID: 19999632 [No Abstract] [Full Text] [Related]
70. Knuckle pad-like keratoderma: a new cutaneous side reaction induced by tegafur. Won YH; Seo JJ; Kim SJ; Lee SC; Chun IK Int J Dermatol; 1998 Apr; 37(4):315-7. PubMed ID: 9585908 [No Abstract] [Full Text] [Related]
71. Black lunula caused by Tegafur. Chen GY; Chao SC; Chen W Acta Derm Venereol; 2004; 84(3):238-9. PubMed ID: 15202848 [No Abstract] [Full Text] [Related]
72. Palmar-plantar erythrodysaesthesia syndrome and other cutaneous side-effects after treatment with Tegafur. Rios-Buceta L; Buezo GF; Peñas PF; Dauden E; Fernandez-Herrera J; Garcia-Diez A Acta Derm Venereol; 1997 Jan; 77(1):80-1. PubMed ID: 9059693 [No Abstract] [Full Text] [Related]
73. Chemotherapy-induced acral erythema due to Tegafur. Bastida J; Díaz-Cascajo C; Borghi S Acta Derm Venereol; 1997 Jan; 77(1):72-3. PubMed ID: 9059686 [No Abstract] [Full Text] [Related]
74. Maintenance tegafur-uracil versus observation following an adjuvant oxaliplatin-based regimen in patients with stage III colon cancer after radical resection: study protocol for a randomized controlled trial. Yeh YS; Tsai HL; Huang CW; Wei PL; Sung YC; Tang HC; Wang JY Trials; 2017 Apr; 18(1):191. PubMed ID: 28441966 [TBL] [Abstract][Full Text] [Related]
75. Oral tegafur-uracil plus folinic acid versus intravenous 5-fluorouracil plus folinic acid as adjuvant chemotherapy of colon cancer. Kim DJ; Kim TI; Suh JH; Cho YS; Shin SK; Kang JK; Kim NK; Kim WH Yonsei Med J; 2003 Aug; 44(4):665-75. PubMed ID: 12950123 [TBL] [Abstract][Full Text] [Related]
76. Chronic liver failure induced by long-term administration of tegafur: a case report. Matsumoto M; Nakao K; Matsumoto H; Iwata K; Ohta Y; Kanai K; Takahashi K; Akima M Hepatogastroenterology; 1998; 45(24):2372-5. PubMed ID: 9951926 [TBL] [Abstract][Full Text] [Related]